Leilei Yang

3.7k total citations · 2 hit papers
102 papers, 2.7k citations indexed

About

Leilei Yang is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Leilei Yang has authored 102 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 23 papers in Immunology and 21 papers in Oncology. Recurrent topics in Leilei Yang's work include Genomics and Phylogenetic Studies (13 papers), Nanoplatforms for cancer theranostics (11 papers) and Microbial Community Ecology and Physiology (10 papers). Leilei Yang is often cited by papers focused on Genomics and Phylogenetic Studies (13 papers), Nanoplatforms for cancer theranostics (11 papers) and Microbial Community Ecology and Physiology (10 papers). Leilei Yang collaborates with scholars based in China, United States and Czechia. Leilei Yang's co-authors include Zhi‐Jun Sun, Qi‐Chao Yang, Wen‐Feng Zhang, Yao Xiao, Lin‐Lin Bu, Liang Mao, Lei Wu, Xiao Yang, Shao‐Chen Yang and Guang‐Tao Yu and has published in prestigious journals such as Advanced Materials, Nano Letters and Advanced Functional Materials.

In The Last Decade

Leilei Yang

99 papers receiving 2.6k citations

Hit Papers

Microenvironment‐Responsive Prodrug‐Induced Pyroptosis Bo... 2021 2026 2022 2024 2021 2025 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leilei Yang China 27 1.1k 750 728 646 319 102 2.7k
Aubie Shaw United States 16 1.2k 1.1× 661 0.9× 680 0.9× 814 1.3× 388 1.2× 26 2.6k
Longzhen Zhang China 34 991 0.9× 688 0.9× 602 0.8× 864 1.3× 439 1.4× 186 3.6k
Shivani Soni United States 24 915 0.8× 837 1.1× 1.1k 1.4× 330 0.5× 354 1.1× 112 3.2k
Hyewon Youn South Korea 30 1.6k 1.4× 298 0.4× 500 0.7× 1.0k 1.6× 365 1.1× 108 3.6k
Andreas Evdokiou Australia 40 2.1k 1.9× 576 0.8× 1.4k 1.9× 488 0.8× 512 1.6× 100 4.2k
Jianhua Wang China 22 682 0.6× 372 0.5× 699 1.0× 722 1.1× 188 0.6× 106 2.9k
Carla Herberts Netherlands 18 1.1k 1.0× 1.3k 1.8× 1.3k 1.8× 500 0.8× 348 1.1× 30 4.1k
Dan Huang China 33 1.5k 1.4× 467 0.6× 665 0.9× 291 0.5× 92 0.3× 134 3.3k

Countries citing papers authored by Leilei Yang

Since Specialization
Citations

This map shows the geographic impact of Leilei Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leilei Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leilei Yang more than expected).

Fields of papers citing papers by Leilei Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leilei Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leilei Yang. The network helps show where Leilei Yang may publish in the future.

Co-authorship network of co-authors of Leilei Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Leilei Yang. A scholar is included among the top collaborators of Leilei Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leilei Yang. Leilei Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
He, Wei, et al.. (2024). Revitalizing antitumor immunity: Leveraging nucleic acid sensors as therapeutic targets. Cancer Letters. 588. 216729–216729. 5 indexed citations
3.
Chen, Ziyang, Hongchao Liu, Bin Li, et al.. (2024). Insights into the CO-mediated deactivation mechanism for dimethyl ether carbonylation reaction over a H-MOR catalyst. Applied Catalysis A General. 677. 119701–119701.
4.
Sun, Zhi‐Jun, et al.. (2024). Hsa_circ_0092355 Accelerates Papillary Thyroid Cancer Progression by Regulating the miR-543/PDE5A Pathway. Hormone and Metabolic Research. 56(5). 381–391. 1 indexed citations
6.
Gu, Yue, Junhui Zhang, Wang Ma, et al.. (2023). Ecological Factors Driving Tree Diversity across Spatial Scales in Temperate Forests, Northeast China. Forests. 14(6). 1241–1241. 1 indexed citations
7.
Chen, Siyu, et al.. (2023). Metabolic plasticity sustains the robustness of Caenorhabditis elegans embryogenesis. EMBO Reports. 24(12). e57440–e57440. 4 indexed citations
8.
Yang, Leilei, et al.. (2023). Emerging roles of plasmacytoid dendritic cell crosstalk in tumor immunity. Cancer Biology and Medicine. 20(10). 1–20. 5 indexed citations
9.
Zhang, Liang, Yao Xiao, Qi‐Chao Yang, et al.. (2022). Staggered Stacking Covalent Organic Frameworks for Boosting Cancer Immunotherapy. Advanced Functional Materials. 32(29). 77 indexed citations
10.
Wu, Cong‐Cong, et al.. (2021). Overexpression of LAG3, TIM3, and A2aR in adenoid cystic carcinoma and mucoepidermoid carcinoma. Oral Diseases. 29(1). 175–187. 2 indexed citations
11.
Liang, Ling, Leilei Yang, Wenjie Wang, et al.. (2021). Calcium Phosphate‐Reinforced Metal‐Organic Frameworks Regulate Adenosine‐Mediated Immunosuppression. Advanced Materials. 33(45). e2102271–e2102271. 42 indexed citations
12.
Zhang, Gehong, et al.. (2020). Modifying thin film composite membrane with zeolitic imidazolate framework-8@polydopamine for enhanced antifouling property. Chemosphere. 248. 125956–125956. 26 indexed citations
13.
Wu, Zhi‐Zhong, Shuo Wang, Qi‐Chao Yang, et al.. (2020). Increased Expression of SHMT2 Is Associated With Poor Prognosis and Advanced Pathological Grade in Oral Squamous Cell Carcinoma. Frontiers in Oncology. 10. 588530–588530. 16 indexed citations
14.
Wu, Lei, Liang Mao, Jianfeng Liu, et al.. (2019). Blockade of TIGIT/CD155 Signaling Reverses T-cell Exhaustion and Enhances Antitumor Capability in Head and Neck Squamous Cell Carcinoma. Cancer Immunology Research. 7(10). 1700–1713. 164 indexed citations
15.
Chen, Lei, Qi‐Chao Yang, Yicun Li, et al.. (2019). Targeting CMTM6 Suppresses Stem Cell–Like Properties and Enhances Antitumor Immunity in Head and Neck Squamous Cell Carcinoma. Cancer Immunology Research. 8(2). 179–191. 105 indexed citations
16.
Xiong, Hong‐Gang, Hao Li, Yao Xiao, et al.. (2019). Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma. Journal of Experimental & Clinical Cancer Research. 38(1). 278–278. 82 indexed citations
17.
Chen, Wei, et al.. (2018). Experimental study of low-temperature combustion characteristics of shale rocks. Combustion and Flame. 194. 285–295. 22 indexed citations
18.
Liu, Jianfeng, Lei Wu, Leilei Yang, et al.. (2018). Blockade of TIM3 relieves immunosuppression through reducing regulatory T cells in head and neck cancer. Journal of Experimental & Clinical Cancer Research. 37(1). 44–44. 98 indexed citations
19.
Meng, Fanwei, Xuan Cheng, Leilei Yang, et al.. (2008). Accelerated re-epithelialization in Dpr2 -deficient mice is associated with enhanced response to TGFβ signaling. Journal of Cell Science. 121(17). 2904–2912. 28 indexed citations
20.
Teng, Yan, Xiaochen Pan, Guan Yang, et al.. (2006). Synergistic Function of Smad4 and PTEN in Suppressing Forestomach Squamous Cell Carcinoma in the Mouse. Cancer Research. 66(14). 6972–6981. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026